Teleflex Inc. (NYSE: TFX) has agreed to buy Vascular Solutions Inc. (Nasdaq: VASC) for approximately $1 billion. The deal for the target’s products will improve Teleflex’s research and development efforts, all while reducing the cost of procedures.
Vascular Solutions is Minneapolis-based medical company focused on improving diagnostic and vascular procedures. The target’s products cover an array of procedural needs, including: specialty catheters, aspiration catheters, electrophysiology, drainage, embolization, guidewires, hemostasis, interventional accessories, radial access, snares, and vein treatment. Vascular Solutions’ product line of more than 90 proprietary devices is sold to cardiologists, radiologists, vein specialists and electrophysiologists in the U.S. and worldwide through its distribution network.